Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its participation in two upcoming investor conferences in February.

Chairman and chief executive officer, Bob Weiler, and senior vice president and chief financial officer, Chris Menard, will participate in:

  • The UBS 20th Annual Global Healthcare Services Conference in New York City. The presentation is scheduled for Monday, February 8, 2010 at 2:00 p.m. ET.
  • The Thomas Weisel Partners Technology and Telecom Conference 2010 in San Francisco. The fireside chat is scheduled for Tuesday, February 9, 2010 at 2:05 p.m. PT.

The events will be webcast live and will be available by visiting the Investors section of the company’s website at www.phaseforward.com. The webcasts will be archived on the company’s website for 30 days after the conference ends.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, SGS, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.

Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Phase Forward Charts.
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Phase Forward Charts.